Price
No data yet.
Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management - Bonds
- Beta
- 0.66
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
IBDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
130+8.33%Social Signal Score
Mentions (4)
- Newsinvestors.com·14d ago·Positive
AI-Fueled Precision Oncology Firm Guardant Health Is In Focus. Here's Why. Earning a spot on the IBD Leaderboard and IBD 50, Guardant Health stress tests a breakout.
View source ↗ - Newsprnewswire.com·42d ago·Neutral
Inspire Corporate Bond Fund (IBD) Receives 5-star Overall Morningstar Rating™ Among 155 Corporate Bond Funds BOISE, Idaho, Aug. 25, 2026 /PRNewswire/ -- Inspire Investing is pleased to announce that the Inspire Corporate Bond ETF (NYSE: IBD) has been awarded a 5-star Overall Morningstar Rating™ for the 5-year period out of 155 Corporate Bond funds as of 7/31/26. Morningstar's rating system evaluates funds based on their risk-adjusted returns relative to category peers, with the top 10% of funds …
View source ↗ - Newszacks.com·42d ago·Positive
Can Spyre's SPY772 HS Study Broaden Its Growth Story Beyond Core IBD? SYRE expands into HS with SPY772, testing whether dual-pathway inhibition can strengthen outcomes in SKYLIGHT.
View source ↗ - Newszacks.com·57d ago·Positive
Is Inspire Corporate Bond ETF (IBD) a Strong ETF Right Now? Launched on 07/10/2017, the Inspire Corporate Bond ETF (IBD) is a smart beta exchange traded fund offering broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
View source ↗
Congress trades
No disclosed congressional trades in IBD.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.